SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia Journal Article


Authors: Hoshii, T.; Perlee, S.; Kikuchi, S.; Rahmutulla, B.; Fukuyo, M.; Masuda, T.; Ohtsuki, S.; Soga, T.; Nabet, B.; Kaneda, A.
Article Title: SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia
Abstract: Histone methyltransferase SETD1A is critical for acute myeloid leukemia (AML) cell survival, but the molecular mechanism driving SETD1A gene regulation remains elusive. To delineate the role of SETD1A, we utilize a protein degrader technology to induce rapid SETD1A degradation in AML cell lines. SETD1A degradation results in immediate downregulation of transcripts associated with DNA repair and heme biosynthesis pathways. CRISPR-based functional analyses and metabolomics reveal an essential role of SETD1A to maintain mitochondrial respiration in AML cells. These SETD1A targets are enriched in head-to-head (H2H) genes. SETD1A degradation disrupts a non-enzymatic SETD1A domain-dependent cyclin K function, increases the Ser5P RNA polymerase II (RNAPII) at the transcriptional start site (TSS), and induces the promoter-proximal pausing of RNAPII in a strand-specific manner. This study reveals a non-enzymatic role for SETD1A in transcriptional pause release and provides insight into the mechanism of RNAPII pausing and its function in cancer. © 2022 The Author(s)
Keywords: leukemia; elongation; cyclin k; setd1a; cp: molecular biology; heme biosynthesis
Journal Title: Cell Reports
Volume: 41
Issue: 9
ISSN: 2211-1247
Publisher: Cell Press  
Date Published: 2022-11-29
Start Page: 111727
Language: English
DOI: 10.1016/j.celrep.2022.111727
PROVIDER: scopus
PUBMED: 36450243
PMCID: PMC9771694
DOI/URL:
Notes: Article -- Export Date: 1 December 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sarah Catherine Perlee
    6 Perlee